Tel:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@anticorps-enligne.fr

Cripto-1 anticorps (Internal Region)

TDGF1.3 Reactivité: Humain ELISA, WB Hôte: Lapin Polyclonal unconjugated
Pubmed (5 références)
N° du produit ABIN233828
$658.50
Plus frais de port $45.00 et $20.00 pour carboglace
Destination: Etats-Unis
Envoi sous 1 à 2 jours ouvrables
  • Antigène See all Cripto-1 (TDGF1.3) products
    Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))
    Épitope
    • 2
    • 1
    Internal Region
    Reactivité
    • 5
    • 3
    • 1
    Humain
    Hôte
    • 3
    • 3
    • 1
    Lapin
    Clonalité
    • 4
    • 3
    Polyclonal
    Conjugué
    • 5
    • 2
    Cet anticorp Cripto-1 est non-conjugé
    Application
    • 5
    • 3
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB)
    Attributs du produit
    Concentration Definition: by UV absorbance at 280 nm
    Immunogène
    This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to an sequence of human Cripto-1 protein.
    Isotype
    IgG
  • Indications d'application
    This affinity purified antibody has been tested for use in ELISA and western blotting.  Specific conditions for reactivity should be optimized by the end user.  Expect a band approximately 21 kDa in size corresponding to Cripto-1 by western blotting in the appropriate cell lysate or extract.  Cripto-1 is reported as a 188 amino acid protein with a molecular weight of 21.1 kDa.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.66 mg/mL
    Buffer
    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Ligtenberg, Witt, Galvez-Cancino, Sette, Lundqvist, Lladser, Kiessling: "Cripto-1 vaccination elicits protective immunity against metastatic melanoma." dans: Oncoimmunology, Vol. 5, Issue 5, pp. e1128613, (2016) (PubMed).

    Strizzi, Margaryan, Gerami, Haghighat, Harms, Madonna, Botti, Ascierto, Hendrix: "Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi." dans: Oncology letters, Vol. 12, Issue 2, pp. 1349-1354, (2016) (PubMed).

    Tysnes, Satran, Mork, Margaryan, Eide, Petersen, Strizzi, Hendrix: "Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients." dans: Translational oncology, Vol. 6, Issue 6, pp. 732-41, (2014) (PubMed).

    Strizzi, Margaryan, Gilgur, Hardy, Normanno, Salomon, Hendrix: "The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics." dans: Cell cycle (Georgetown, Tex.), Vol. 12, Issue 9, pp. 1450-6, (2013) (PubMed).

    Malchenko, Galat, Seftor, Vanin, Costa, Seftor, Soares, Hendrix: "Cancer hallmarks in induced pluripotent cells: new insights." dans: Journal of cellular physiology, Vol. 225, Issue 2, pp. 390-3, (2010) (PubMed).

  • Antigène
    Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))
    Autre désignation
    Cripto-1 TDGF1 (TDGF1.3 Produits)
    Sujet
    This antibody is designed, produced, and is suitable for Cancer, Immunology and Nuclear Signaling research. Human Cripto-1 (CR-1), also known as Teratocarcinoma-derived growth factor 1 (TDGF1), is a member of the epidermal growth factor (EGF)-GFC family and has been implicated in both embryogenesis and carcinogenesis.  During early vertebrate development, CR-1 functions as a co-receptor for Nodal, a transforming growth factor b (TGFb) family member, and is essential for mesoderm and endoderm formation and anterior-posterior and left-right axis establishment.  In adult tissues, CR-1 is expressed at a low level in all stages of mammary gland development, and expression increases during pregnancy and lactation.  Over-expression of CR-1 in mouse mammary epithelial cells leads to their transformation in vitro, and when injected in mammary glands, CR-1 produces ductal hyperplasias.
    Synonyms: Cripto1 antibody, Cripto1 growth factor antibody, Epidermal growth factor like cripto protein CR1 antibody, TDGF 1 antibody
    ID gène
    6997, 4507425
    UniProt
    P13385
Vous êtes ici:
Support technique